메뉴 건너뛰기




Volumn 13, Issue 1, 2014, Pages 84-90

Statin use is not associated with liver related mortality

Author keywords

Liver disease; Mortality; Statin

Indexed keywords

CLOFIBRATE; COLESTIPOL; COLESTYRAMINE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER ENZYME; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; PROBUCOL; SIMVASTATIN;

EID: 84893646143     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)30908-1     Document Type: Article
Times cited : (17)

References (22)
  • 1
    • 84855987832 scopus 로고    scopus 로고
    • A.D.A.M. Medical Encyclopedia
    • Coronary Heart Disease. A.D.A.M. Medical Encyclopedia. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0004449/.
    • Coronary Heart Disease
  • 2
    • 84893708361 scopus 로고    scopus 로고
    • Statin Hepatotoxicity: Is it a Real Concern?
    • Sikka P, Saxena KK, Kapoor S. Statin Hepatotoxicity: Is it a Real Concern? Heart Views 2011; 12(3): 104-6.
    • (2011) Heart Views , vol.12 , Issue.3 , pp. 104-106
    • Sikka, P.1    Saxena, K.K.2    Kapoor, S.3
  • 3
    • 84865310442 scopus 로고    scopus 로고
    • The safety and effectiveness of statins as treatment for HIV-dyslipidemia: The evidence so far and the future challenges
    • Ahmed MH, Al-Atta A, Hamad MA. The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges. Expert Opin Pharmacother 2012.
    • (2012) Expert Opin Pharmacother
    • Ahmed, M.H.1    Al-Atta, A.2    Hamad, M.A.3
  • 5
    • 80054739232 scopus 로고    scopus 로고
    • Effectiveness of preprocedural statin therapy on clinical outcomes for patients with stable coronary artery disease after percutaneous coronary interventions
    • Ko DT, Wijeysundera HC, Yun L, Austin PC, Cantor WJ, Tu JV. Effectiveness of preprocedural statin therapy on clinical outcomes for patients with stable coronary artery disease after percutaneous coronary interventions. Circ Cardiovasc Qual Outcomes 2011; 4(4): 459-66.
    • (2011) Circ Cardiovasc Qual Outcomes , vol.4 , Issue.4 , pp. 459-466
    • Ko, D.T.1    Wijeysundera, H.C.2    Yun, L.3    Austin, P.C.4    Cantor, W.J.5    Tu, J.V.6
  • 6
    • 84870487971 scopus 로고    scopus 로고
    • Effects of pitavastatin on cardiac structure and function and on prevention of atrial fibrillation in elderly hypertensive patients
    • Aug 8. [Epub ahead of print
    • Warita S, Kawasaki M, Tanaka R, Ono K, Kojima T, Hirose T, Iwama M, et al. Effects of pitavastatin on cardiac structure and function and on prevention of atrial fibrillation in elderly hypertensive patients. Circ J 2012 Aug 8. [Epub ahead of print]
    • (2012) Circ J
    • Warita, S.1    Kawasaki, M.2    Tanaka, R.3    Ono, K.4    Kojima, T.5    Hirose, T.6    Iwama, M.7
  • 7
    • 84865537236 scopus 로고    scopus 로고
    • Effect of statin therapy on the progression of coronary atherosclerosis
    • [Epub ahead of print]
    • Tian J, Gu X, Sun Y, Ban X, Xiao Y, Hu S, Yu B. Effect of statin therapy on the progression of coronary atherosclerosis. BMC Cardiovasc Disord 2012; 12(1): 70. [Epub ahead of print]
    • (2012) BMC Cardiovasc Disord , vol.12 , Issue.1 , pp. 70
    • Tian, J.1    Gu, X.2    Sun, Y.3    Ban, X.4    Xiao, Y.5    Hu, S.6    Yu, B.7
  • 8
    • 80053971380 scopus 로고    scopus 로고
    • Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells
    • Ali OF, Growcott EJ, Butrous GS, Wharton J. Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells. Respir Res 2011; 12: 137.
    • (2011) Respir Res , vol.12 , pp. 137
    • Ali, O.F.1    Growcott, E.J.2    Butrous, G.S.3    Wharton, J.4
  • 9
    • 77956025285 scopus 로고    scopus 로고
    • Hepatotoxicity fears contribute to underutilization of statin medications by primary care physicians
    • Rzouq FS, Volk ML, Hatoum HH, Talluri SK, Mummadi RR, Sood GK. Hepatotoxicity fears contribute to underutilization of statin medications by primary care physicians. Am J Med Sci 2010; 340(2): 89-93.
    • (2010) Am J Med Sci , vol.340 , Issue.2 , pp. 89-93
    • Rzouq, F.S.1    Volk, M.L.2    Hatoum, H.H.3    Talluri, S.K.4    Mummadi, R.R.5    Sood, G.K.6
  • 10
    • 84861591910 scopus 로고    scopus 로고
    • The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
    • Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142(7): 1592-609.
    • (2012) Gastroenterology , vol.142 , Issue.7 , pp. 1592-1609
    • Chalasani, N.1    Younossi, Z.2    Lavine, J.E.3    Diehl, A.M.4    Brunt, E.M.5    Cusi, K.6    Charlton, M.7
  • 11
    • 84858830168 scopus 로고    scopus 로고
    • A 2012 clinical update for internists in adult nonalcoholic fatty liver disease
    • Younossi ZM, Venkatesan C. A 2012 clinical update for internists in adult nonalcoholic fatty liver disease. Panminerva Med 2012; 54(1): 29-37.
    • (2012) Panminerva Med , vol.54 , Issue.1 , pp. 29-37
    • Younossi, Z.M.1    Venkatesan, C.2
  • 12
    • 84861747780 scopus 로고    scopus 로고
    • Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users
    • Cohen JD, Brinton EA, Ito MK, Jacobson TA. Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users. J Clin Lipidol 2012; 6(3): 208-15.
    • (2012) J Clin Lipidol , vol.6 , Issue.3 , pp. 208-215
    • Cohen, J.D.1    Brinton, E.A.2    Ito, M.K.3    Jacobson, T.A.4
  • 13
    • 84876744562 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration
    • FDA Expands Advice on Statin Risks. U.S. Food and Drug Administration. http://www.fda.gov/ForConsumers/Con-sumerUpdates/ucm293330.htm
    • FDA Expands Advice On Statin Risks
  • 15
    • 70449096299 scopus 로고    scopus 로고
    • Drug-induced liver injury associated with statins
    • Russo MW, Scobey M, Bonkovsky HL. Drug-induced liver injury associated with statins. Semin Liver Dis 2009; 29(4): 412-22.
    • (2009) Semin Liver Dis , vol.29 , Issue.4 , pp. 412-422
    • Russo, M.W.1    Scobey, M.2    Bonkovsky, H.L.3
  • 16
    • 0004015092 scopus 로고    scopus 로고
    • U.S. department of health and human services (DHHS), third national health and nutrition examination survey, 1988-1994, NHANES III household adult data file. public use data file documentation number 77560. Hyattsville, MD. Centers for Disease Control and Prevention
    • U.S. department of health and human services (DHHS). National center for health statistics. third national health and nutrition examination survey, 1988-1994, NHANES III household adult data file. public use data file documentation number 77560. Hyattsville, MD. Centers for Disease Control and Prevention; 1996.
    • (1996) National Center For Health Statistics
  • 18
    • 0021813187 scopus 로고
    • Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
    • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28(7): 412-19.
    • (1985) Diabetologia , vol.28 , Issue.7 , pp. 412-419
    • Matthews, D.R.1    Hosker, J.P.2    Rudenski, A.S.3    Naylor, B.A.4    Treacher, D.F.5    Turner, R.C.6
  • 19
    • 77957196987 scopus 로고    scopus 로고
    • Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: A population-based study
    • Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut 2010; 59(10): 1410-15.
    • (2010) Gut , vol.59 , Issue.10 , pp. 1410-1415
    • Stepanova, M.1    Rafiq, N.2    Younossi, Z.M.3
  • 20
    • 84855970707 scopus 로고    scopus 로고
    • Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing
    • Björnsson E, Jacobsen EI, Kalaitzakis E. Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing. J Hepatol 2012; 56: 374-80.
    • (2012) J Hepatol , vol.56 , pp. 374-380
    • Björnsson, E.1    Jacobsen, E.I.2    Kalaitzakis, E.3
  • 21
    • 84859316565 scopus 로고    scopus 로고
    • Hepatotoxicity associated with statins
    • Teschke R. Hepatotoxicity associated with statins. Ann Hepatol 2012; 11; 418-20.
    • (2012) Ann Hepatol , vol.11 , pp. 418-420
    • Teschke, R.1
  • 22
    • 84865140816 scopus 로고    scopus 로고
    • Rare statin hepatotoxicity: Convincing evidence based on breakthrough case study
    • Teschke R, Frenzel C, Wolff A, Eickhoff A. Rare statin hepatotoxicity: Convincing evidence based on breakthrough case study. J Hepatol 2012; 57: 699-700.
    • (2012) J Hepatol , vol.57 , pp. 699-700
    • Teschke, R.1    Frenzel, C.2    Wolff, A.3    Eickhoff, A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.